Posaconazol (Noxafil®) suspensión y comprimidos no deben utilizarse indistintamente sin realizar un ajuste de dosis
Alejandro Gabriel Catanzariti
Evidencia. Actualización en la Práctica Ambulatoria · 2016
doi:10.51987/evidencia.v19i3.6443 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Posaconazole is a broad-spectrum triazole family antifungal used in the treatment and prophylaxis of invasive fungalinfections in patients 13 years of age or older, in which other treatments have not been effective or tolerated.In June 2016 the European Medicines Agency and the Spanish Agency for Medicines and Health Products issued awarning alerting that because of differences in the frequency of dosing, interactions with food and plasma levels achievedby the drug, tablets and posaconazole suspension are not interchangeable
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.